Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of HIV pre-exposure prophylaxis (PrEP) awards under Executive Order 14168 on gender ideology in the U.S. 2012-2025.

Public health in practice (Oxford, England)·2026
Same author

When Less Is More: Volume Considerations in the Treatment of <i>Enterococcus faecalis</i> Endocarditis.

Open forum infectious diseases·2026
Same author

Sporadic retinal capillary hemangioma regresses with belzutifan.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Efficacy of Treating Post-Traumatic Epilepsy in Children With Ketogenic Diet.

Journal of child neurology·2026
Same author

Outcomes of Prosthetic Valve Endocarditis Managed by a Multidisciplinary Endocarditis Team: A Retrospective Cohort Study.

CJC open·2026
Same author

Lessons From One FQHC's Experience With Artificial Intelligence.

The Journal of ambulatory care management·2025

Related Experiment Video

Updated: May 26, 2026

Animal Model of Implant-Associated Infections in Mice
07:02

Animal Model of Implant-Associated Infections in Mice

Published on: June 27, 2025

The Impact of MOUD Initiation in Patients With Injection Drug Use-Associated Infective Endocarditis.

Seth Losiewicz1, Bennett Collis2, Sami El-Dalati3

  • 1Department of Internal Medicine, University of Kentucky Medical Center, Lexington, Kentucky, USA.

Open Forum Infectious Diseases
|May 25, 2026
PubMed
Summary

Medications for opioid use disorder (MOUD) significantly reduced 30-day mortality in patients with infective endocarditis linked to injection drug use. MOUD showed a nonsignificant trend toward increased antibiotic treatment completion.

Keywords:
endocarditisinjection drug usemedications for opioid use disordermultidisciplinary teams

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

Related Experiment Videos

Last Updated: May 26, 2026

Animal Model of Implant-Associated Infections in Mice
07:02

Animal Model of Implant-Associated Infections in Mice

Published on: June 27, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Addiction Medicine

Background:

  • Infective endocarditis is a serious complication in patients with injection drug use.
  • Opioid use disorder (OUD) presents significant challenges in managing infective endocarditis.
  • Medications for opioid use disorder (MOUD) are crucial for comprehensive patient care.

Purpose of the Study:

  • To evaluate the impact of MOUD initiation on treatment outcomes for patients with injection drug use-associated infective endocarditis.
  • To assess the association between MOUD and antibiotic treatment completion and mortality rates.

Main Methods:

  • Retrospective, single-center study design.
  • Evaluation of 218 patients with injection drug use-associated infective endocarditis.
  • Comparison of outcomes between patients receiving MOUD and those who did not.

Main Results:

  • Initiation of MOUD was associated with a significant reduction in 30-day postdischarge mortality.
  • A nonsignificant increase in antibiotic treatment completion was observed with MOUD initiation.
  • MOUD did not show a significant impact on 90-day mortality.

Conclusions:

  • MOUD initiation is associated with improved short-term survival in patients with injection drug use-associated infective endocarditis.
  • Further research is needed to explore the long-term effects of MOUD on mortality and treatment adherence.
  • Integrating MOUD into the care of patients with infective endocarditis may improve patient outcomes.